AI-Powered Clinical Tool Aims To Prevent Opioid Disorder Relapse (UF Pharmacy)
UF researchers led the development of PROTECT, an AI-powered clinical tool that uses machine learning to predict relapse risk in patients undergoing buprenorphine treatment for opioid use disorder, supported by a National Institutes of Health grant.
Myosin Therapeutics Awarded $3 Million NIH Grant To Advance Clinical Trial for MT-110 in Methamphetamine Use Disorder
UF Startup Myosin Therapeutics, Inc., a biotechnology company developing innovative therapies for cancer and neurological disorders, announced that it has been awarded a $3 million grant from NIDA, part of NIH.